Oriental Aromatics profit and loss

Latest FY26

Revenue: ₹1,031cr+11.0% on FY25
EBITDA: ₹68.0cr−27.2% on FY25
Net profit: ₹3.3cr−90.4% on FY25
EPS: ₹0.98−90.4% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	1,065	1,031	928	836	849	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	10.3	9.6	3.3	7.3	5.7
	1,075	1,040	932	844	855
	688	649	615	533	631
	34.6	27.2	20.7	0.0	0.0
	−2.0	9.4	−75.8	38.9	−53.9
	83.7	83.8	76.0	53.9	52.8
	35.5	35.8	25.4	20.4	13.0
	31.1	31.1	23.7	19.8	19.4
	191	194	199	164	165
	1,062	1,030	884	830	827
	69.7	68.0	93.4	46.9	54.2
	38.6	36.9	69.7	27.1	34.8
Profit
	13.5	10.8	47.6	14.1	27.5
	13.5	10.8	47.6	14.1	27.5
	9.6	8.7	12.9	4.7	7.5
	−1.4	−1.2	0.4	0.2	0.3
	8.2	7.5	13.3	5.0	7.7
	5.3	3.3	34.3	9.1	19.7
	5.3	3.3	34.3	9.1	19.7
	0.1	−0.1	−0.9	−0.1	−0.1
	5.4	3.2	33.4	9.0	19.7
	—	3.3	34.3	—	—
Per share
	₹1.58	₹0.98	₹10.20	₹2.71	₹5.87
	₹0.97	₹0.00	₹0.00	₹0.00	₹0.00
Other comprehensive income — detail
	0.1	−0.1	−0.9	—	—
	—	−0.1	−1.2	—	—
	0.5	−0.0	−0.3	—	—
	—	—	—	0.1	0.1
	—	—	—	—	0.0
	—	—	—	−0.0	0.0
	—	3.3	34.3	—	—
Per share — as-filed variants
	₹1.58	₹0.98	₹10.20	₹2.71	₹5.87
	₹0.97	₹0.00	₹0.00	₹0.00	₹0.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	344	346	369	265	272
	32.3%	33.5%	39.7%	31.7%	32.1%
Adjusted (ex-exceptional items) — derived
	13.5	10.8	47.6	14.1	27.5
	5.3	3.3	34.3	9.1	19.7
	₹1.58	₹0.98	₹10.20	₹2.71	₹5.87

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

OAL₹607.05

Oriental Aromatics Limited

· Chemicals

Annual Quarterly₹ CrorePeersIGPL PCBL PARADEEP INDOBORAX SPLPETRO SUMICHEM JUBLINGREA VIDHIINGMcap ₹2,043 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	849.1	836.4	928.3	1,030.8	1,065.1
Other Income	5.7	7.3	3.3	9.6	10.3
Total Income	854.8	843.7	931.5	1,040.4	1,075.4
Expenses
+ Cost of Materials Consumed	630.7	532.5	614.6	648.5	688.2
+ Purchases of Stock-in-Trade	0.0	0.0	20.7	27.2	34.6
+ Changes in Inventories	-53.9	38.9	-75.8	9.4	-2.0
+ Employee Benefit Expense	52.8	53.9	76.0	83.8	83.7
+ Finance Costs	13.0	20.4	25.4	35.8	35.5
+ Depreciation & Amortisation	19.4	19.8	23.7	31.1	31.1
+ Other Expenses	165.2	164.1	199.4	193.9	190.7
Total Expenses	827.3	829.6	883.9	1,029.6	1,061.9
EBITDA	54.2	46.9	93.4	68.0	69.7
EBIT	34.8	27.1	69.7	36.9	38.6
Profit
PBT before Exceptional Items	27.5	14.1	47.6	10.8	13.5
Pretax Income	27.5	14.1	47.6	10.8	13.5
+ Current Tax	7.5	4.7	12.9	8.7	9.6
+ Deferred Tax	0.3	0.2	0.4	-1.2	-1.4
Tax Expense	7.7	5.0	13.3	7.5	8.2
Net Income	19.7	9.1	34.3	3.3	5.3
+ Net Income — Continuing Ops	19.7	9.1	34.3	3.3	5.3
+ Other Comprehensive Income	-0.1	-0.1	-0.9	-0.1	0.1
Total Comprehensive Income	19.7	9.0	33.4	3.2	5.4
Net Income to Common	—	—	34.3	3.3	—
Per Share
Basic EPS	5.87	2.71	10.20	0.98	1.58
Diluted EPS	0.00	0.00	0.00	0.00	0.97
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-0.9	-0.1	0.1
+ Items NOT to be Reclassified to P&L	—	—	-1.2	-0.1	—
+ Tax on Items NOT to be Reclassified	—	—	-0.3	-0.0	0.5
+ Tax on Items NOT to be Reclassified — alt tag	0.1	0.1	—	—	—
+ Items to be Reclassified to P&L	0.0	—	—	—	—
+ Tax on Items to be Reclassified — alt tag	0.0	-0.0	—	—	—
Comprehensive Income — Owners of Parent	—	—	34.3	3.3	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	5.87	2.71	10.20	0.98	1.58
Diluted EPS — Continuing Operations	0.00	0.00	0.00	0.00	0.97
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	272.3	264.9	368.7	345.7	344.2
Gross Margin %	32.07	31.67	39.72	33.53	32.32
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	27.5	14.1	47.6	10.8	13.5
Net Income Adj (tax-effected)	19.7	9.1	34.3	3.3	5.3
EPS Adj	5.87	2.71	10.20	0.98	1.58
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	5.00	5.00	5.00	5.00	5.00
Paid Up Equity Capital	16.8	16.8	16.8	16.8	16.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.